Uterine cancer

Disease5 papers

Humans1
In silico3

Trial sponsors

Greater Baltimore Medical Center
1 trialPhase 2/31 person
Bay Area Gynecology Oncology
1 trialPhase 2200 people
University Hospital, Ghent
1 trialPhase 243 people
Montefiore Medical Center
1 trialPhase 230 people
Jeanne Drisko, MD, CNS, FACN
1 trialPhase 225 people
Mark H. Einstein
1 trialPhase 223 people
University of Nebraska
1 trialPhase 1/2200 people
M.D. Anderson Cancer Center
1 trialPhase 140 people

Funding

National Cancer InstituteUS$1.9m2 grants since 2026

Comparative Modeling of Uterine Cancer
National Cancer InstituteTufts Medical CenterUS$1.3m2026–2031
Comparative Modeling for the Prevention and Control of Uterine Cancer
National Cancer InstituteTufts Medical CenterUS$618.1k2026–2027

Latest

6

The Lancet Regional Health EuropeHumans19 Sep

Trends in early-onset cancer incidence rates in the Nordic countries (2003-2022): a population-based study

Therapeutic Advances in Reproductive HealthReview18 Sep

The clinical relevance of obesity and glucagon-like peptide-1-based therapies for chronic weight management in patients treated by obstetrician-gynecologists and gynecologists: A non-systematic narrative review

Zhongguo Yi Xue Ke Xue Yuan Xue Bao Acta Academiae Medicinae SinicaeIn silico28 Aug

Analysis and Model Prediction of the Burden of Early-Onset Cancer Attributed to Overweight and Obesity in the Chinese Population From 1990 to 2021

bioRxivIn silicoPreprint28 Aug

Epigenetic Clocks Reveal Age Acceleration and Shared Methylation Remodeling Across Cancers

Epigenetic clock

medRxivIn silicoPreprint25 Aug

MetaFemina: development and evaluation of a large language model-assisted platform for automated meta-analysis of nutritional exposures and breast, ovarian, and uterine cancer risk

Reproductive system

Cancer CellReview18 Aug

Biological aging and the hidden architecture of early-onset cancer risk